Low-dose aspirin versus placebo as adjunctive treatment in bipolar disorder (the Aspirin-Bipolar RCT): Results of exploratory biomarker analyses

Progress in Neuro-Psychopharmacology & Biological Psychiatry · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles